Add BrightSurf on Google Email

Purdue-designed tool helps guide brain cancer surgery

A Purdue-designed tool uses mass spectrometry to analyze brain tumor tissue, providing color-coded images that reveal the location and nature of tumor cells. The tool has been successfully used in two surgical procedures, offering a significant improvement over current methods.

SourcePurdue University·JournalProceedings of the National Academy of Sciences·DateJul 2, 2014

Herpes-loaded stem cells used to kill brain tumors

Researchers developed herpes-loaded stem cells that significantly improved survival rates in mice with glioblastoma multiforme when applied to tumors. The treatment used mesenchymal stem cells as drug delivery vehicles, allowing oncolytic viruses to replicate and kill residual cancer cells.

SourceHarvard University·JournalJNCI Journal of the National Cancer Institute·DateMay 16, 2014

Human fat: A trojan horse to fight brain cancer?

Johns Hopkins researchers have successfully used stem cells derived from human body fat to deliver biological treatments directly to the brains of mice with glioblastoma, a deadly form of brain tumor. The treatment extended the mice's lives by an average of 24 days, offering new hope for treating aggressive brain cancer in humans.

SourceJohns Hopkins Medicine·JournalClinical Cancer Research·DateMay 1, 2014

Gender influences symptoms of genetic disorder

A new study reveals that girls with NF1 are at greater risk of vision loss from brain tumors, while boys are more vulnerable to learning disabilities. The research identifies gender-linked differences in male mice that may help explain these findings.

SourceWashU Medicine·JournalAnnals of Neurology·DateFeb 6, 2014

Stopping tumors in their path

Researchers from McGill University have identified two transcription factors controlling the expression of genes involved in GBM tumourigenesis. Impairing these proteins could significantly reduce the ability of brain tumour-initiating cells to give rise to brain tumors.

SourceMcGill University·JournalNature Communications·DateJan 8, 2014

In search of a treatment for a rare bone cancer

Researchers at Johns Hopkins Medicine found that erlotinib, a drug approved to treat lung cancer, substantially shrunk chordoma tumors in mice. The study offers new hope for chordoma patients who have exhausted traditional treatments and have limited financial incentives for pharmaceutical companies to develop new drugs.

SourceJohns Hopkins Medicine·JournalPLOS ONE·DateDec 11, 2013

Boosting the immune system to treat brain cancer

A team of researchers has discovered a mechanism that boosts the immune system and reduces brain tumor growth, paving the way for new treatment options. The study identified a commercially available drug, amphotericin B, as a potential novel treatment for patients with glioblastoma, a frequently lethal form of brain cancer.

SourceUniversity of Calgary·JournalNature Neuroscience·DateDec 8, 2013

New immunotherapy for malignant brain tumors

Researchers developed a new immunotherapy approach that successfully treated glioblastoma, a fatal brain tumor, by stimulating the immune system and inducing tumor rejection. The treatment, combining intra-tumoral Interleukin-12 with CTLA-4 blockade, achieved a success rate of up to 80% in preclinical trials.

SourceUniversity of Zurich·JournalJournal of Experimental Medicine·DateNov 25, 2013

A new view of brain tumors

Researchers have developed a new imaging technology, SRS microscopy, that allows surgeons to distinguish between brain tissue and tumors at a microscopic level. This technique can guide surgeons in the operating room and potentially improve surgical outcomes for patients with glioblastoma multiforme.

SourceHarvard University·JournalScience Translational Medicine·DateSep 4, 2013